-
1
-
-
26944473246
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
-
Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-27.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1407-1427
-
-
Edwards, B.K.1
Brown, M.L.2
Wingo, P.A.3
-
4
-
-
36749058297
-
When even people at high risk do not take up colorectal cancer screening
-
Ladabaum U. When even people at high risk do not take up colorectal cancer screening. Gut 2007;56:1648-50.
-
(2007)
Gut
, vol.56
, pp. 1648-1650
-
-
Ladabaum, U.1
-
5
-
-
35349016919
-
Chemoprevention of colorectal cancer
-
Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion 2007;76:51-67.
-
(2007)
Digestion
, vol.76
, pp. 51-67
-
-
Das, D.1
Arber, N.2
Jankowski, J.A.3
-
6
-
-
34548266731
-
Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention
-
Boursi B, Arber N. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr Pharm Des 2007;13:2274-82.
-
(2007)
Curr Pharm Des
, vol.13
, pp. 2274-2282
-
-
Boursi, B.1
Arber, N.2
-
7
-
-
33947533150
-
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force
-
Rostom A, Dube C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007;146:376-89.
-
(2007)
Ann Intern Med
, vol.146
, pp. 376-389
-
-
Rostom, A.1
Dube, C.2
Lewin, G.3
-
8
-
-
10744220122
-
Estrogen plus progestin and colorectal cancer in postmenopausal women
-
Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
-
(2004)
N Engl J Med
, vol.350
, pp. 991-1004
-
-
Chlebowski, R.T.1
Wactawski-Wende, J.2
Ritenbaugh, C.3
-
9
-
-
0033134701
-
Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
-
Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82.
-
(1999)
Am J Med
, vol.106
, pp. 574-582
-
-
Grodstein, F.1
Newcomb, P.A.2
Stampfer, M.J.3
-
10
-
-
0029916051
-
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats
-
Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
-
(1996)
J Clin Invest
, vol.98
, pp. 671-679
-
-
Volpert, O.V.1
Ward, W.F.2
Lingen, M.W.3
-
11
-
-
0345700262
-
Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists
-
Molteni A, Ward WF, Ts'ao CH, et al. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Curr Pharm Des 2003;9:751-61.
-
(2003)
Curr Pharm Des
, vol.9
, pp. 751-761
-
-
Molteni, A.1
Ward, W.F.2
Ts'ao, C.H.3
-
13
-
-
0036239832
-
HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
-
Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19.
-
(2002)
Leukemia
, vol.16
, pp. 508-519
-
-
Wong, W.W.1
Dimitroulakos, J.2
Minden, M.D.3
Penn, L.Z.4
-
15
-
-
0035498516
-
Angiotensin-converting enzyme inhibitors and the risk of cancer: A population-based cohort study in Denmark
-
Friis S, Sorensen HT, Mellemkjaer L, et al. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 2001;92:2462-70.
-
(2001)
Cancer
, vol.92
, pp. 2462-2470
-
-
Friis, S.1
Sorensen, H.T.2
Mellemkjaer, L.3
-
16
-
-
0031050146
-
Calcium-channel blockers and risk of cancer
-
Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet 1997;349:525-8.
-
(1997)
Lancet
, vol.349
, pp. 525-528
-
-
Jick, H.1
Jick, S.2
Derby, L.E.3
Vasilakis, C.4
Myers, M.W.5
Meier, C.R.6
-
17
-
-
0026785561
-
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
-
The SOLVD Investigators
-
The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
-
(1992)
N Engl J Med
, vol.327
, pp. 685-691
-
-
-
18
-
-
0032543880
-
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
-
Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352: 179-84.
-
(1998)
Lancet
, vol.352
, pp. 179-184
-
-
Lever, A.F.1
Hole, D.J.2
Gillis, C.R.3
-
19
-
-
34548019063
-
Statins and the risk of colorectal cancer: A meta-analysis of 18 studies involving more than 1.5 million patients
-
Bonovas S, Filioussi K, Flordellis CS, Sitaras NM. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007;25:3462-8.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3462-3468
-
-
Bonovas, S.1
Filioussi, K.2
Flordellis, C.S.3
Sitaras, N.M.4
-
20
-
-
42249096112
-
Statins and cancer: A meta-analysis of case-control studies
-
Taylor ML, Wells BJ, Smolak MJ. Statins and cancer: a meta-analysis of case-control studies. Eur J Cancer Prev 2008;17:259-68.
-
(2008)
Eur J Cancer Prev
, vol.17
, pp. 259-268
-
-
Taylor, M.L.1
Wells, B.J.2
Smolak, M.J.3
-
21
-
-
29944446607
-
Statins and cancer risk: A meta-analysis
-
Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a meta-analysis. JAMA 2006;295:74-80.
-
(2006)
JAMA
, vol.295
, pp. 74-80
-
-
Dale, K.M.1
Coleman, C.I.2
Henyan, N.N.3
Kluger, J.4
White, C.M.5
-
22
-
-
33750627697
-
Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
-
Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol 2006;24:4808-17.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4808-4817
-
-
Bonovas, S.1
Filioussi, K.2
Tsavaris, N.3
Sitaras, N.M.4
-
23
-
-
34548096170
-
Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case-control study
-
Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer 2007;121:1325-30.
-
(2007)
Int J Cancer
, vol.121
, pp. 1325-1330
-
-
Hoffmeister, M.1
Chang-Claude, J.2
Brenner, H.3
-
25
-
-
14844292583
-
Cancer risk among statin users: A population-based cohort study
-
Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114:643-7.
-
(2005)
Int J Cancer
, vol.114
, pp. 643-647
-
-
Friis, S.1
Poulsen, A.H.2
Johnsen, S.P.3
-
26
-
-
0034726387
-
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
-
Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000;160:2363-8.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2363-2368
-
-
Blais, L.1
Desgagne, A.2
LeLorier, J.3
-
27
-
-
2942754163
-
The risk of cancer in users of statins
-
Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ. The risk of cancer in users of statins. J Clin Oncol 2004;22:2388-94.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2388-2394
-
-
Graaf, M.R.1
Beiderbeck, A.B.2
Egberts, A.C.3
Richel, D.J.4
Guchelaar, H.J.5
-
29
-
-
33846111227
-
Statins and the risk of lung, breast, and colorectal cancer in the elderly
-
Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 2007;115:27-33.
-
(2007)
Circulation
, vol.115
, pp. 27-33
-
-
Setoguchi, S.1
Glynn, R.J.2
Avorn, J.3
Mogun, H.4
Schneeweiss, S.5
-
30
-
-
34547499117
-
Risk of colorectal cancer in patients prescribed statins, nonsteroidal antiinflammatory drugs, and cyclooxygenase-2 inhibitors: Nested casecontrol study
-
Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF. Risk of colorectal cancer in patients prescribed statins, nonsteroidal antiinflammatory drugs, and cyclooxygenase-2 inhibitors: nested casecontrol study. Gastroenterology 2007;133:393-402.
-
(2007)
Gastroenterology
, vol.133
, pp. 393-402
-
-
Vinogradova, Y.1
Hippisley-Cox, J.2
Coupland, C.3
Logan, R.F.4
-
31
-
-
42449116829
-
Screening statins for possible carcinogenic risk: Up to 9 years of follow-up of 361 859 recipients
-
Friedman GD, Flick ED, Udaltsova N, Chan Pharm DJ, Quesenberry CP, Jr., Habel LA. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients. Pharmacoepidemiol Drug Saf 2007.
-
(2007)
Pharmacoepidemiol Drug Saf
-
-
Friedman, G.D.1
Flick, E.D.2
Udaltsova, N.3
Chan Pharm, D.J.4
Quesenberry Jr., C.P.5
Habel, L.A.6
-
32
-
-
0030600342
-
Calcium-channel blockade and incidence of cancer in aged populations
-
Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-7.
-
(1996)
Lancet
, vol.348
, pp. 493-497
-
-
Pahor, M.1
Guralnik, J.M.2
Ferrucci, L.3
-
33
-
-
0030199181
-
Do calcium channel blockers increase the risk of cancer?
-
Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996;9:695-9.
-
(1996)
Am J Hypertens
, vol.9
, pp. 695-699
-
-
Pahor, M.1
Guralnik, J.M.2
Salive, M.E.3
Corti, M.C.4
Carbonin, P.5
Havlik, R.J.6
-
34
-
-
0141563692
-
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years
-
Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003;98:1504-13.
-
(2003)
Cancer
, vol.98
, pp. 1504-1513
-
-
Li, C.I.1
Malone, K.E.2
Weiss, N.S.3
Boudreau, D.M.4
Cushing-Haugen, K.L.5
Daling, J.R.6
-
35
-
-
0030826328
-
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
-
Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997;80:1438-47.
-
(1997)
Cancer
, vol.80
, pp. 1438-1447
-
-
Fitzpatrick, A.L.1
Daling, J.R.2
Furberg, C.D.3
Kronmal, R.A.4
Weissfeld, J.L.5
-
36
-
-
0026670336
-
Active cell death in hormone-dependent tissues
-
Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992;11:197-220.
-
(1992)
Cancer Metastasis Rev
, vol.11
, pp. 197-220
-
-
Tenniswood, M.P.1
Guenette, R.S.2
Lakins, J.3
Mooibroek, M.4
Wong, P.5
Welsh, J.E.6
-
37
-
-
0023759116
-
Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death
-
Connor J, Sawczuk IS, Benson MC, et al. Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate 1988;13:119-30.
-
(1988)
Prostate
, vol.13
, pp. 119-130
-
-
Connor, J.1
Sawczuk, I.S.2
Benson, M.C.3
-
38
-
-
0027255942
-
Apoptosis and disease
-
Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-4.
-
(1993)
Lancet
, vol.341
, pp. 1251-1254
-
-
Carson, D.A.1
Ribeiro, J.M.2
-
39
-
-
0035254178
-
Is diuretic therapy associated with an increased risk of colon cancer?
-
Tenenbaum A, Motro M, Jonas M, et al. Is diuretic therapy associated with an increased risk of colon cancer? Am J Med 2001;110:143-5.
-
(2001)
Am J Med
, vol.110
, pp. 143-145
-
-
Tenenbaum, A.1
Motro, M.2
Jonas, M.3
-
41
-
-
3042548409
-
Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications
-
Boudreau DM, Doescher MP, Jackson JE, Fishman PA. Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications. Ann Pharmacother 2004;38:1317-8.
-
(2004)
Ann Pharmacother
, vol.38
, pp. 1317-1318
-
-
Boudreau, D.M.1
Doescher, M.P.2
Jackson, J.E.3
Fishman, P.A.4
-
42
-
-
3042798873
-
A population-based osteoporosis screening program: Who does not participate, and what are the consequences?
-
Buist DS, LaCroix AZ, Brenneman SK, Abbott T. A population-based osteoporosis screening program: who does not participate, and what are the consequences? J Am Geriatr Soc 2004;52:1130-7.
-
(2004)
J Am Geriatr Soc
, vol.52
, pp. 1130-1137
-
-
Buist, D.S.1
LaCroix, A.Z.2
Brenneman, S.K.3
Abbott, T.4
-
43
-
-
38449120272
-
The association between statins and cancer incidence in a veterans population
-
Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst 2008;100:134-9.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 134-139
-
-
Farwell, W.R.1
Scranton, R.E.2
Lawler, E.V.3
-
44
-
-
23844508510
-
Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention
-
Zielinski SL. Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention. J Natl Cancer Inst 2005;97:1172-3.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1172-1173
-
-
Zielinski, S.L.1
-
45
-
-
34547670103
-
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
-
Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007;166:348-54.
-
(2007)
Am J Epidemiol
, vol.166
, pp. 348-354
-
-
Brookhart, M.A.1
Patrick, A.R.2
Dormuth, C.3
-
46
-
-
1542329169
-
Statin use and cancer risk in the General Practice Research Database
-
Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer 2004;90:635-7.
-
(2004)
Br J Cancer
, vol.90
, pp. 635-637
-
-
Kaye, J.A.1
Jick, H.2
-
47
-
-
30344441524
-
Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort
-
Jacobs EJ, Rodriguez C, Brady KA, Connell CJ, Thun MJ, Calle EE. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst 2006;98:69-72.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 69-72
-
-
Jacobs, E.J.1
Rodriguez, C.2
Brady, K.A.3
Connell, C.J.4
Thun, M.J.5
Calle, E.E.6
-
48
-
-
0032054681
-
Calcium channel blockers and the risk of cancer
-
Rosenberg L, Rao RS, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-4.
-
(1998)
JAMA
, vol.279
, pp. 1000-1004
-
-
Rosenberg, L.1
Rao, R.S.2
Palmer, J.R.3
-
49
-
-
0028053592
-
Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells
-
Leszczynski D, Zhao Y, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 1994;145:1265-70.
-
(1994)
Am J Pathol
, vol.145
, pp. 1265-1270
-
-
Leszczynski, D.1
Zhao, Y.2
Luokkamaki, M.3
Foegh, M.L.4
-
50
-
-
0028924891
-
Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: The involvement of intracellular calcium and RNA synthesis
-
Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 1995;15:1172-9.
-
(1995)
J Neurosci
, vol.15
, pp. 1172-1179
-
-
Galli, C.1
Meucci, O.2
Scorziello, A.3
Werge, T.M.4
Calissano, P.5
Schettini, G.6
-
51
-
-
0025951117
-
Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro
-
Correale P, Tagliaferri P, Celio L, Genua G, Montagnani S, Bianco AR. Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro. Eur J Cancer 1991;27:1393-5.
-
(1991)
Eur J Cancer
, vol.27
, pp. 1393-1395
-
-
Correale, P.1
Tagliaferri, P.2
Celio, L.3
Genua, G.4
Montagnani, S.5
Bianco, A.R.6
-
52
-
-
0037215258
-
Verapamil is associated with an increased risk of cancer in the elderly: The Rotterdam study
-
Beiderbeck-Noll AB, Sturkenboom MC, van der Linden PD, et al. Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer 2003;39:98-105.
-
(2003)
Eur J Cancer
, vol.39
, pp. 98-105
-
-
Beiderbeck-Noll, A.B.1
Sturkenboom, M.C.2
van der Linden, P.D.3
|